We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$247M
AUM Growth
+$26.9M
Cap. Flow
+$1.99M
Cap. Flow %
0.81%
Top 10 Hldgs %
28.64%
Holding
82
New
13
Increased
21
Reduced
29
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 89.54%
2 Industrials 0.78%
3 Energy 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
1
HCA Healthcare
HCA
$87.2B
$7.97M 3.23%
108,600
-11,400
-10% -$801K
UHS icon
2
Universal Health Services
UHS
$10.2B
$7.73M 3.13%
69,500
-10,500
-13% -$1.1M
BIIB icon
3
Biogen
BIIB
$30B
$7.65M 3.1%
22,534
+7,534
+50% +$2.44M
CELG
4
DELISTED
Celgene Corp
CELG
$7.42M 3%
66,299
+31,299
+89% +$3.3M
MCK icon
5
McKesson
MCK
$100B
$7.2M 2.92%
34,700
+9,700
+39% +$1.97M
DGX icon
6
Quest Diagnostics
DGX
$25.7B
$6.97M 2.82%
104,000
+10,800
+12% +$682K
CYH icon
7
Community Health Systems
CYH
$393M
$6.65M 2.7%
149,314
-32,186
-18% -$1.38M
ZBH icon
8
Zimmer Biomet
ZBH
$18.2B
$6.4M 2.59%
58,092
+19,982
+52% +$2.11M
AGN
9
DELISTED
Allergan plc
AGN
$6.38M 2.59%
24,800
-2,700
-10% -$675K
AMGN icon
10
Amgen
AMGN
$208B
$6.32M 2.56%
39,700
+9,700
+32% +$1.51M
AGN
11
DELISTED
Allergan Inc
AGN
$6.31M 2.56%
29,700
+9,700
+49% +$1.93M
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
$6.1M 2.47%
74,300
+34,300
+86% +$2.39M
COV
13
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$6.08M 2.46%
59,400
-600
-1% -$57.6K
BDX icon
14
Becton Dickinson
BDX
$45.6B
$5.53M 2.24%
+40,693
New +$5.2M
SYK icon
15
Stryker
SYK
$125B
$5.14M 2.08%
54,500
+14,500
+36% +$1.29M
SNN icon
16
Smith & Nephew
SNN
$13.3B
$5.1M 2.06%
138,700
+1,200
+0.9% +$40.4K
VTRS icon
17
Viatris
VTRS
$20.4B
$5.03M 2.04%
+89,200
New +$4.79M
HUM icon
18
Humana
HUM
$43.7B
$4.98M 2.02%
34,700
+4,700
+16% +$642K
THC icon
19
Tenet Healthcare
THC
$20.5B
$4.81M 1.95%
95,000
-20,000
-17% -$1.05M
BMY icon
20
Bristol-Myers Squibb
BMY
$133B
$4.67M 1.89%
79,200
+9,200
+13% +$519K
RAD
21
DELISTED
Rite Aid Corporation
RAD
$4.46M 1.81%
29,680
-10,320
-26% -$1.15M
MNK
22
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4.46M 1.8%
45,000
-10,000
-18% -$920K
UNH icon
23
UnitedHealth
UNH
$376B
$4.32M 1.75%
+42,702
New +$4.05M
HNT
24
DELISTED
HEALTH NET INC
HNT
$4.25M 1.72%
79,400
+26,600
+50% +$1.31M
ESRX
25
DELISTED
Express Scripts Holding Company
ESRX
$3.95M 1.6%
+46,666
New +$3.65M

Similar funds

Sivik Global Healthcare's Q4 2014 Portfolio in Review

As of Q4 2014, Sivik Global Healthcare held 82 positions worth $247M, up 12% from $220M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Sivik Global Healthcare's Q4 2014 filing shows 13 new, 21 increased, 29 reduced and 19 closed positions. Its largest new stake was Becton Dickinson: 40,693 shares worth $5.53M. The largest sale was Labcorp, an estimated $5.03M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Industrials and Energy.

  • Sivik Global Healthcare's largest Q4 2014 buy was Becton Dickinson: 40,693 shares worth $5.53M.
  • Sivik Global Healthcare added most to Celgene Corp in Q4 2014, an estimated $3.3M increase.
  • Sivik Global Healthcare's biggest Q4 2014 reduction was Cencora, cutting an estimated $3.44M.
  • Sivik Global Healthcare fully exited Labcorp in Q4 2014, selling an estimated $5.03M.
  • Sivik Global Healthcare's ten largest holdings make up 29% of its $247M portfolio in Q4 2014.
  • Sivik Global Healthcare opened 13 new positions and closed 19 in Q4 2014.
  • Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $247M.

Based on Sivik Global Healthcare's 13F filing for Q4 2014, filed 7 Jan 2015.